General Hatami said that the second phase of the "Fakhra" vaccine's clinical trial was carried out successfully and the relevant report will be sent to the Health Ministry.
He expressed hope that the third clinical trial phase of the vaccine will begin within the next 15 days.
On Mar 16, 2021, Iran started the first phase of clinical tests on the “Fakhra” vaccine, which has been developed by the Defense Ministry, by injecting a shot to the son of the top martyred nuclear scientist, Dr. Mohsen Fakhrizadeh.
Organization of Defensive Innovation and Research, a department in Iran's Defense Ministry, which was previously led by Dr. Fakhrizadeh, has developed the vaccine. Fakhrizadeh was assassinated on November 28, 2020.
3266**2050
Follow us on Twitter @IrnaEnglish
Your Comment